Philippines - English - FDA (Food And Drug Administration)

ambica international corporation; distributor: macropharma corporation - paracetamol , orphenadrine citrate - film-coated tablet - 650mg/ 35mg

Philippines - English - FDA (Food And Drug Administration)

innogen pharmaceuticals, inc.; distributor: solvang pharmaceuticals, inc. - paracetamol , orphenadrine citrate - tablet - 450 mg/35 mg

Philippines - English - FDA (Food And Drug Administration)

euroasia pharmaceuticals, inc.; distributor: euroasia pharmaceuticals, inc. - paracetamol , orphenadrine citrate - tablet - 650mg/ 50mg

Philippines - English - FDA (Food And Drug Administration)

euroasia pharmaceuticals, inc.; distributor: euroasia pharmaceuticals, inc. - paracetamol , orphenadrine citrate - tablet - 450mg/ 35mg

Canada - English - Health Canada

sterimax inc - orphenadrine citrate - liquid - 30mg - orphenadrine citrate 30mg - miscellaneous skeletal muscle relaxants

Philippines - English - FDA (Food And Drug Administration)

ambica international corporation; distributor: guimhealth pharmaceutical distributor and drugstore - paracetamol , orphenadrine citrate - film-coated tablet - 650 mg/35 mg

Philippines - English - FDA (Food And Drug Administration)

ambica international trading corp.; distributor: ambica international trading corp. - paracetamol , orphenadrine citrate - film-coated tablet - 450mg/ 35mg

Philippines - English - FDA (Food And Drug Administration)

ambica international corporation; distributor: ambica international corporation - paracetamol , orphenadrine citrate - film-coated tablet - 650 mg/35 mg

United States - English - NLM (National Library of Medicine)

stat rx usa llc - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9) - orphenadrine citrate is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculo-skeletal conditions. the mode of action of the drug has not been clearly identified, but may be related to its analgesic properties. orphenadrine citrate does not directly relax tense skeletal muscles in man. contraindicated in patients with glaucoma, pyloric or duodenal obstruction, stenosing peptic ulcers, prostatic hypertrophy or obstruction of the bladder neck, cardiospasm (megaesophagus) and myasthenia gravis. contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.

United States - English - NLM (National Library of Medicine)

carilion materials management - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9) - orphenadrine citrate extended-release tablets, usp are indicated as an adjunct to rest, physical therapy and other measures for the relief of discomfort associated with acute painful musculo skeletal conditions. contraindicated in patients with glaucoma, pyloric or duodenal obstruction, stenosing peptic ulcers, prostatic hypertrophy or obstruction of the bladder neck, cardio-spasm (megaesophagus) and myasthenia gravis. contraindicated in patients who have demonstrated a previous hypersensitivity to the drug. safety and effectiveness in pediatric patients have not been established. orphenadrine citrate has been chronically abused for its euphoric effects.[1] the mood elevating effects may occur at therapeutic doses of orphenadrine.[2]